MedTrace Logo

Homonymous Hemianopia in Childhood

NCT06115317 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2023-11-03

No results posted yet for this study

Summary

The study will consist of two connected components at a single centre. Phase 1 is observational, phenotyping children with Homonymous hemianopia (HH). Phase 2 is a pilot double blind cross over RCT in which segmental prisms are compared with sham prisms in glasses.

Conditions

  • Homonymous Hemianopia

Interventions

OTHER

Prism

Prism

OTHER

Sham

Sham

Sponsors & Collaborators

  • Institute of Child Health

    lead OTHER

Principal Investigators

  • Jugnoo Rahi · GOSH Institute of Child Health

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-04
Primary Completion
2024-03-31
Completion
2025-07-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06115317 on ClinicalTrials.gov